Related Experiment Video
Updated: Jun 2, 2026
07:40
Widespread Transduction of Mouse Neocortical Neurons by Subarachnoid Injection of AAV2
Published on: May 23, 2025
Virus vectors for gene delivery to the nervous system
F Smith1, D Jacoby, X O Breakefield
1Eunice Kennedy Shriver Center, Waltham, MA, Neurology Service, Massachusetts General Hospital, and Neurology Department, Harvard Medical School, Boston, MA, USA.
Restorative Neurology and Neuroscience
|May 10, 2011
Summary
Virus vectors are crucial for delivering genes to the nervous system, offering efficient delivery with varying capacities and infection methods. Ongoing developments aim to improve gene expression stability and reduce toxicity for therapeutic applications.
Area of Science:
- Neuroscience
- Gene Therapy
- Molecular Biology
Background:
- Gene delivery to the nervous system is challenging due to the need for efficient and safe methods.
- Virus vectors are the most effective tools for delivering genes to the central nervous system.
- Understanding the characteristics of different virus vectors is crucial for optimizing gene therapy.
Purpose of the Study:
- To compare the advantages and disadvantages of four major virus vectors used for gene delivery to the nervous system.
- To evaluate vector efficiency, transgene capacity, cell tropism, integration, stability, and toxicity.
- To highlight the potential of these vectors for future therapeutic applications.
Main Methods:
- Comparative analysis of herpes virus, adenovirus, retrovirus, and adeno-associated virus (AAV) vectors.
- Evaluation of vector-specific properties including titer, transgene capacity, and cell infectivity.
- Assessment of gene expression stability, integration potential, and associated neuropathogenicity.
Main Results:
- Herpes and adenovirus vectors achieve higher titers but have limitations in transgene capacity and toxicity.
- Retrovirus and AAV vectors yield lower titers but offer genome integration and lower neuropathogenicity.
- All vectors face challenges with long-term gene expression stability due to promoter down-regulation.
Conclusions:
- Each virus vector type presents a unique profile of benefits and drawbacks for neural gene delivery.
- Adeno-associated virus (AAV) vectors show promise due to their integration capabilities and lower toxicity.
- Continued advancements in vector technology are expected to enhance their therapeutic potential for neurological disorders.
